Rapamycin (Sirolimus), the mTOR inhibitor used in both humans and canines to inhibit cell proliferation in various cancers, including melanoma, has shown similar IC50 values in inhibiting melanoma cell growth in both species. The gene discussed is MTOR; the disease is cancer.